Clinical trials for prostate cancer
46 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Phase 3
Prostate cancer
#NCT06625970
Adenocarcinoma
Localized
PSMA PET Negative
None
Systemic Treatment-Naive
Surgery
Radiotherapy
Internal Vectorised Radiotherapy (IVR)
Gustave Roussy (Villejuif)
UNICANCER
Phase 3
Prostate cancer
#NCT06136624
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Centre Jean Perrin (Clermont Ferrand ), Centre Eugene Marquis (Rennes), Institut de cancérologie du Gard (Nîmes), Centre Hospitalier de la Côte Basque (Bayonne), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Merck Sharp & Dohme LLC
Phase 3
Prostate cancer
#NCT06496581
Adenocarcinoma
Metastatic Hormone-sensitive
None
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Centre Eugene Marquis (Rennes), Gustave Roussy (Villejuif), Institut Paoli-Calmettes (Marseille)
UNICANCER
Phase 3
Prostate cancer
#NCT06120491
Metastatic Hormone-sensitive
Other mutation
Surgery
Radiotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Hôpital Cochin (Paris ), Centre Léon Bérard (Lyon), Hôpital Henri-Mondor AP-HP (Créteil), Centre de Cancérologie du Grand Montpellier (Montpellier) (and 13 more...)
AstraZeneca
Phase 3
Prostate cancer
#NCT05939414
Biochemical recurrence
Metastatic Hormone-sensitive
PSMA PET Positive
1
Surgery
Radiotherapy
Centre Jean Perrin (Clermont Ferrand ), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Henri Becquerel (Rouen ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain) (and 1 more...)
Novartis
Phase 3
Prostate cancer
#NCT05884398
Adenocarcinoma
Metastatic Hormone-sensitive
None
Hormone therapy
Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Institut Bergonié (Bordeaux)
Janssen
Phase 3
Prostate cancer
#NCT05794906
Adenocarcinoma
Biochemical recurrence
PSMA PET Positive
1
Surgery
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital privé Le Bois - Ramsay Santé (Lille), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy) (and 12 more...)
Bayer
Phase 3
Prostate cancer
#NCT05116475
Adenocarcinoma
Metastatic Hormone-sensitive
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Oncologie RadioThérapie 37 (Chambray-lès-Tours), Hôpital Privé des Peupliers - Ramsay Santé (Paris)
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 3
Prostate cancer
#NCT04916613
Metastatic Hormone-sensitive
None
Systemic Treatment-Naive
Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Institut Bergonié (Bordeaux) (and 40 more...)
UNICANCER
Phase 3
Prostate cancer
#NCT04181203
Adenocarcinoma
Biochemical recurrence
PSMA PET Negative
None
Surgery
Radiotherapy
Hormone therapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Oscar Lambret (Lille), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez) (and 1 more...)
UNICANCER